Novartis will pay $150 million upfront to Schrödinger, in a pact announced Tuesday to work together on several ...
GSK has licensed a small molecule for Parkinson's and is teaming up on additional targets for the disease and another ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback